WellKiwis is a study to follow newborns over multiple years, to see how a child’s earliest exposures to the flu virus or flu vaccine influences their immune responses to subsequent flu exposures as a child grows.
The WellKiwis Influenza Study is looking for 600 birth mothers and their children, due to be born between 1 October 2019 to 30 September 2022, to take part in this important study. The purpose of the WellKiwis study is to provide information that will help scientists develop a universal flu vaccine that could put an end to flu pandemiics and save millions of lives around the world.
WellKiwis volunteers are being sought in the Wellington region only. This is defined as Wellington central, Hutt Valley and Porirua (the jurisdictions covered by the CCDHB and HVDHB).
Listen to WellKiwis Lead, Dr Sue Huang to learn more about WellKiwisYouTube
If you are interested in taking part in this study, you can find information here about how you and your baby can help develop better vaccines to prevent flu in the future.
To find out more more about the study and sign-up, please contact WellKiwis - phone 0800 493555 (08004WELLKIWI) or email Wellkiwis@esr.cri.nz(external link)
You can also go to www.wellkiwis.co.nz(external link) for more information or speak to your lead maternity carer, GP or clinician to find out more information and to register your interest.
WellKiwis Participant Information
If you’re interested in signing up to participate in this important study, you can find detailed information here:
You might find answers to some of your questions here in our Frequently Asked Questions [PDF, 910 KB] (FAQs)
Privacy & Confidentiality
Your child’s test results and information are confidential.
No personal identifiable information will be published.
ESR is leading the WellKiwis study with New Zealand ethics approval (NTX11.11.102.AM42&52). WellKiwis is a member of SHIVERS (Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance) project family. SHIVERS is a long series of research on influenza virus and vaccine and the Wellkiwis study is the third in its series (SHIVERS-III).
WellKiwis is a multi-agency collaboration including Lead Maternity Carer (LMC), the Universities of Otago and Auckland, Regional Public Health, the Capital Coast and Hutt Valley District Health Boards, and Malaghan Institute of Medical Research. It is a part of a large international collaboration - DIVINCI led by St. Jude Children’s Research Hospital that is enrolling about 3,000 children from three different sites around the world - Los Angeles, Managua, Nicaragua and Wellington. WellKiwis is funded by the United States National Institutes of Health (US NIH).